Inclusion of indomethacin in XDP 3050 of Mesoporous silica using wet Methods of formulations

Authors

  • Muhammad Kabiru Rabiu Author
    • Ahmad Shamsudeen Abdullahi Author
      • arba Bashir Author
        • Yunusa Buhari Idris Author

          DOI:

          https://doi.org/10.33003/chemclass-2025-0904/09

          Keywords:

          API, DSC IMC

          Abstract

          Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) characterized by poor water solubility, which negatively affects its bioavailability. In this study, three mesoporous silica excipients (Syloid silica, XDP 3050) were formulated with indomethacin, a model drug with poor aqueous solubility, to enhance the rate and extent of drug dissolution. While other mesoporous silica materials have been investigated in previous studies, the effects of these specific Syloid silica-based excipients in combination with indomethacin remain unexplored. This work demonstrates a significant enhancement in both the extent and rate of drug release for all three Syloid silica formulations at 1:1, 1:2, and 1:3 drug-to-silica ratios over 45 minutes. The dissolution profiles of the three silica types were found to differ, which can be attributed to the physicochemical differences between them. All formulations showed a significant improvement in drug release when compared to the dissolution profile of pure indomethacin. This enhancement is likely due to the large surface area of mesoporous silica, which improves wettability and facilitates drug dissolution. In conclusion, this study confirms that Syloid silica-based excipients can be effectively used to enhance the dissolution and potentially the bioavailability of poorly soluble compounds like indomethacin. Furthermore, the release profiles can be tailored based on the choice of Syloid silica excipient. The latter part of this study also presents the analysis and characterization of indomethacin using Differential Scanning Calorimetry (DSC), X-ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR), and Scanning Electron Microscopy (SEM), with a specific focus on the inclusion of the drug in mesoporous silica.

          Downloads

          Download data is not yet available.

          References

          R

          Additional Files

          Published

          2025-12-30

          Data Availability Statement

          None

          Issue

          Section

          Original Research Articles

          How to Cite

          Inclusion of indomethacin in XDP 3050 of Mesoporous silica using wet Methods of formulations. (2025). ChemClass Journal, 9(4), 115-128. https://doi.org/10.33003/chemclass-2025-0904/09

          Share

          Most read articles by the same author(s)